Inventor · disambiguated record
Anthony B. Cooper
Also filed as: COOPER ANTHONY · COOPER ANTHONY B · COOPER ANTHONY BYRON
11 granted patents·13 pending applications·35 citations·filing 2018–2025
89Inventor score
Top patents by PatentIndex Score
24 records- 0196US11186645B2Isolated nucleic acids encoding anti-sortilin antibodiesALECTOR LLC·Filed 2020·Granted Nov 30, 2021·4 cites·48 claims
- 0293US11208488B2Methods of increasing progranulin levels using anti-Sortilin antibodiesALECTOR LLC·Filed 2018·Granted Dec 28, 2021·4 cites·44 claims
- 0391US2025092144A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2024·Application pending·0 cites
- 0490US10308718B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 4, 2019·6 cites·21 claims
- 0589US11339223B2Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2018·Granted May 24, 2022·2 cites·59 claims
- 0689US10329349B2Anti-TIGIT antibodiesITEOS THERAPEUTICS SA·Filed 2018·Granted Jun 25, 2019·10 cites·26 claims
- 0788US11396546B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Jul 26, 2022·2 cites·22 claims
- 0887US11447566B2Anti-tissue factor antibodies, antibody-drug conjugates, and related methodsICONIC THERAPEUTICS INC·Filed 2021·Granted Sep 20, 2022·4 cites·40 claims
- 0985US11439705B2Anti-TIGIT antibodiesiTeos Belgium SA·Filed 2019·Granted Sep 13, 2022·3 cites·15 claims
- 1082US2025297016A1Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 1180US2024309097A2Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryROSENTHAL ARNON·Filed 2022·Application pending·0 cites
- 1279US2022185899A1Methods of increasing progranulin levels using anti-sortilin antibodiesALECTOR LLC·Filed 2021·Application pending·0 cites
- 1379US2022185898A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2021·Application pending·0 cites
- 1477US12358991B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jul 15, 2025·0 cites·52 claims
- 1577US12297277B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 13, 2025·0 cites·53 claims
- 1677US2025361322A1Anti-tissue factor antibodies, antibody-drug conjugates, and related methodsICONIC THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1774US2023181731A1Anti-TIGIT AntibodiesiTeos Belgium SA·Filed 2022·Application pending·0 cites
- 1873US2023190931A1Anti-TIGIT AntibodiesiTeos Belgium SA·Filed 2022·Application pending·0 cites
- 1971US12215167B2Anti-tissue factor antibodies, antibody-drug conjugates, and related methodsICONIC THERAPEUTICS LLC·Filed 2022·Granted Feb 4, 2025·0 cites·11 claims
- 2068US2022396622A1Fc variants with reduced effector functionADIMAB LLC·Filed 2022·Application pending·0 cites
- 2162US2020407445A1Anti-tigit antibodiesITEOS THERAPEUTICS SA·Filed 2018·Application pending·0 cites
- 2260US2021087271A1Fc variants with reduced effector functionADIMAB LLC·Filed 2020·Application pending·0 cites
- 2359US2022153871A1Anti-Tissue Factor Antibodies, Antibody-Drug Conjugates, and Related MethodsICONIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2448US2024317892A1Anti-adam12 antibodies and chimeric antigen receptors, and compositions and methods comprisingJAVELIN ONCOLOGY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anthony B. Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →